Physician profile
Arjun D Sinha
NPI 1942468657
$50,472.23
in general payments reported to CMS, 2019-2025
6 companies · $36K in 2025
The $36K reported for 2025 was more than what 98% of Nephrology (Internal Medicine) providers received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $115 · 2021: $12.78 · 2022: $24.27 · 2023: $204 · 2024: $14K · 2025: $36K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $50K · Food and Beverage: $221.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $50,100.00 |
| Food and Beverage | $220.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $46,500.00 | 2024-2025 | |
| Vertex Pharmaceuticals Incorporated | $3,600.00 | 2025 | |
| Abbott Laboratories | $215.65 | 2022-2023 | Mitraclip |
| Astrazeneca Pharmaceuticals LP | $114.61 | 2019 | |
| Boston Scientific Corporation | $41.97 | 2021-2024 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arjun Sinha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.